Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study

In Japan, government support for human papillomavirus (HPV) vaccination began in November 2010. However, the mass media repeatedly reported on severe adverse events. The Japanese Ministry of Health, Labor and Welfare suspended proactive recommendations for HPV vaccines in June 2013. Japan’s HPV vacc...

Full description

Bibliographic Details
Main Authors: Akiko Tozawa-Ono, Masaharu Kamada, Katsuhiro Teramoto, Hitoshi Hareyama, Shoji Kodama, Tokuzo Kasai, Osamu Iwanari, Tomoe Koizumi, Nobuyoshi Ozawa, Mitsuaki Suzuki, Katsuyuki Kinoshita
Format: Article
Language:English
Published: Taylor & Francis Group 2021-04-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2020.1817715
_version_ 1797677282103394304
author Akiko Tozawa-Ono
Masaharu Kamada
Katsuhiro Teramoto
Hitoshi Hareyama
Shoji Kodama
Tokuzo Kasai
Osamu Iwanari
Tomoe Koizumi
Nobuyoshi Ozawa
Mitsuaki Suzuki
Katsuyuki Kinoshita
author_facet Akiko Tozawa-Ono
Masaharu Kamada
Katsuhiro Teramoto
Hitoshi Hareyama
Shoji Kodama
Tokuzo Kasai
Osamu Iwanari
Tomoe Koizumi
Nobuyoshi Ozawa
Mitsuaki Suzuki
Katsuyuki Kinoshita
author_sort Akiko Tozawa-Ono
collection DOAJ
description In Japan, government support for human papillomavirus (HPV) vaccination began in November 2010. However, the mass media repeatedly reported on severe adverse events. The Japanese Ministry of Health, Labor and Welfare suspended proactive recommendations for HPV vaccines in June 2013. Japan’s HPV vaccination rate dropped from 70% to less than 1% in 2017. We examined cervical cancer screening results in terms of abnormal cytology, histology, and HPV vaccination status among 11,903 women aged 20 to 25 y in the fiscal year 2015. The overall rate of HPV vaccination was 26.1% (3,112/11,903). Regarding cytology, the rate of atypical squamous cells of undetermined significance (ASC-US) or worse was 3.3% (103/3,112) in women who received HPV vaccination (vaccine (+) women) and 5.6% (496/8,791) in women who did not (vaccine (-) women). The rate of high-grade squamous intraepithelial lesion (HSIL) or worse was 0.26% (8/3,112) in vaccine (+) women and 0.81% (72/8,791) in vaccine (-) women. Regarding histology, the rate of cervical intraepithelial neoplasia 1 or worse (CIN1+) was 1.4% (42/3,112) in vaccine (+) women and 2.1% (178/8,791) in vaccine (-) women. The rates of CIN2+ and CIN3+ were similar regardless of vaccination. We found a significantly lower incidence of CIN in vaccine (+) women. These results suggest that the resumption of recommending HPV vaccination as primary prevention for cervical cancer is needed in Japan.
first_indexed 2024-03-11T22:41:51Z
format Article
id doaj.art-69729d0a1fb848a5a95d1bf8f4b3886a
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T22:41:51Z
publishDate 2021-04-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-69729d0a1fb848a5a95d1bf8f4b3886a2023-09-22T08:51:51ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2021-04-0117495095410.1080/21645515.2020.18177151817715Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality studyAkiko Tozawa-Ono0Masaharu Kamada1Katsuhiro Teramoto2Hitoshi Hareyama3Shoji Kodama4Tokuzo Kasai5Osamu Iwanari6Tomoe Koizumi7Nobuyoshi Ozawa8Mitsuaki Suzuki9Katsuyuki Kinoshita10Toyoko HospitalShikoku Central HospitalYamanashi Koseiren Health Care CenterSapporo Maternity Women’s JR-Tower ClinicNiigata Minami HospitalChiba Foundation for Health Promotion& Disease PreventionShimane Prefectural Central HospitalDokkyo Medical University Saitama Medical Center: KoshigayaOzawa Women’s General ClinicShin-Yurigaoka General HospitalSeijyo Kinoshita HospitalIn Japan, government support for human papillomavirus (HPV) vaccination began in November 2010. However, the mass media repeatedly reported on severe adverse events. The Japanese Ministry of Health, Labor and Welfare suspended proactive recommendations for HPV vaccines in June 2013. Japan’s HPV vaccination rate dropped from 70% to less than 1% in 2017. We examined cervical cancer screening results in terms of abnormal cytology, histology, and HPV vaccination status among 11,903 women aged 20 to 25 y in the fiscal year 2015. The overall rate of HPV vaccination was 26.1% (3,112/11,903). Regarding cytology, the rate of atypical squamous cells of undetermined significance (ASC-US) or worse was 3.3% (103/3,112) in women who received HPV vaccination (vaccine (+) women) and 5.6% (496/8,791) in women who did not (vaccine (-) women). The rate of high-grade squamous intraepithelial lesion (HSIL) or worse was 0.26% (8/3,112) in vaccine (+) women and 0.81% (72/8,791) in vaccine (-) women. Regarding histology, the rate of cervical intraepithelial neoplasia 1 or worse (CIN1+) was 1.4% (42/3,112) in vaccine (+) women and 2.1% (178/8,791) in vaccine (-) women. The rates of CIN2+ and CIN3+ were similar regardless of vaccination. We found a significantly lower incidence of CIN in vaccine (+) women. These results suggest that the resumption of recommending HPV vaccination as primary prevention for cervical cancer is needed in Japan.http://dx.doi.org/10.1080/21645515.2020.1817715cytologycervical intraepithelial neoplasiahuman papillomavirus vaccinationjapan
spellingShingle Akiko Tozawa-Ono
Masaharu Kamada
Katsuhiro Teramoto
Hitoshi Hareyama
Shoji Kodama
Tokuzo Kasai
Osamu Iwanari
Tomoe Koizumi
Nobuyoshi Ozawa
Mitsuaki Suzuki
Katsuyuki Kinoshita
Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study
Human Vaccines & Immunotherapeutics
cytology
cervical intraepithelial neoplasia
human papillomavirus vaccination
japan
title Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study
title_full Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study
title_fullStr Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study
title_full_unstemmed Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study
title_short Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study
title_sort effectiveness of human papillomavirus vaccination in young japanese women a retrospective multi municipality study
topic cytology
cervical intraepithelial neoplasia
human papillomavirus vaccination
japan
url http://dx.doi.org/10.1080/21645515.2020.1817715
work_keys_str_mv AT akikotozawaono effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT masaharukamada effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT katsuhiroteramoto effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT hitoshihareyama effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT shojikodama effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT tokuzokasai effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT osamuiwanari effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT tomoekoizumi effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT nobuyoshiozawa effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT mitsuakisuzuki effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy
AT katsuyukikinoshita effectivenessofhumanpapillomavirusvaccinationinyoungjapanesewomenaretrospectivemultimunicipalitystudy